BIOE — Bio Essence Income Statement
0.000.00%
- $25.85m
- $27.88m
- $0.55m
- 12
- 22
- 28
- 10
Annual income statement for Bio Essence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.826 | 0.959 | 0.888 | 0.622 | 0.552 |
Cost of Revenue | |||||
Gross Profit | 0.172 | 0.227 | 0.298 | 0.328 | 0.277 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 2.54 | 1.79 | 1.75 | 1.13 | 1.34 |
Operating Profit | -1.72 | -0.833 | -0.858 | -0.511 | -0.789 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.7 | -0.593 | -0.644 | -0.525 | -0.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.7 | -0.596 | -0.648 | -0.528 | -0.803 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.7 | -0.596 | -0.648 | -0.81 | -0.972 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.7 | -0.596 | -0.648 | -0.81 | -0.972 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.052 | -0.018 | -0.02 | -0.016 | -0.022 |